Pulmobiotics, backed by Invivo Ventures, receives 1.9m euros to develop ‘living medicine’ for lung cancer

by Invivo Capital

Researchers at Pulmobiotics, a start-up founded in 2020 at the Centre for Genomic Regulation (CRG) in Barcelona backed by Invivo Ventures, have begun work on a ‘living medicine’ to improve the eff...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Alantra advises Precinmac on its acquisi...

by Alantra

This transaction reinforces Alantra’s continued momentum in Aerospac...

Photos Stream